Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

Total article views   HTML views PDF downloads Totals
19,057 Dovepress* 15,754+ 3,741 19,495
PubMed Central* 3,303 1,838 5,141
Totals 19,057 5,579 24,636
*Since 31 July 2012
+Since July 2016

View citations on PubMed Central and Google Scholar